Who is this test for?
This test is for people experiencing symptoms consistent with COVID-19 and at high risk of having an active infection.
How does this solution work?
We offer a home-based solution for individuals estimated to be at higher risk for COVID-19. This includes a healthcare professional coming to your home and collecting a swab sample that will be tested for qualitative detection of RNA from SARS-CoV-2.
What locations do you service?
We're working alongside the Texas state government and partnered organizations to provide at-home testing facilitated by healthcare professionals and this is currently available only in Austin and the Greater Houston area.
How old do I need to be to order this test?
You must be 18 years of age or older to order this test.
Who is this test for?
This test is for people who want to detect if they’ve been exposed to the COVID-19 virus. This test may be right for you if you are asymptomatic and have not experienced symptoms consistent with COVID-19 in the past 10 days. It is not intended to diagnose someone who is currently sick with COVID-19
How does this solution work?
The imaware™ home collection kit is easy to use, painless and requires only 3-5 drops of blood. You’ll receive the kit in the mail, draw your sample and send it back to our partnered labs using the provided package. Your results will be sent to you within 5 days over email.
What locations do you service?
This test is currently available everywhere in the United States except for New York.
How old do I need to be to order this test?
You must be 18 years of age or older to order this test
Please complete this initial assessment to estimate your risk for COVID-19 and determine recommended next steps.
This assessment is currently intended only for the Respiratory Coronavirus Nasal Swab Test. Our Coronavirus Antibody Test will be available in June 2020 and we will update this assessment then to reflect this testing option.
Your Personalized Screening and Risk Assessment
Your Personalized Screening and Risk Assessment
Based on your assessment, it is not recommended to go to an assessment center or emergency department or to be tested for the novel Coronavirus/COVID-19.
It is recommended to take preventative measures to reduce the likelihood of being infected with COVID-19. If you develop symptoms of respiratory illness, such as fever, cough and difficulty breathing you should retake this assessment. If you experience a medical emergency at any time you should call 911. For more information, please refer to the CDC website https://www.cdc.gov/coronavirus/2019-ncov/index.html
Based on your assessment, it is not recommended to go to an assessment center or emergency department or to be tested for the novel Coronavirus/COVID-19.
It is recommended that you stay at home and self-isolate for at least 14 days. Avoid contact with others as much as possible. If you develop symptoms of respiratory illness, such as fever, cough and difficulty breathing you should retake this assessment. If you experience a medical emergency at any time you should call 911. For more information, please refer to the CDC website https://www.cdc.gov/coronavirus/ 2019-ncov/if-you-are-sick/index.html
Based on your assessment, it is not recommended to go to an assessment center or emergency department or to be tested for the novel Coronavirus/COVID-19.
It is recommended that you stay at home and self-isolate for at least 14 days. Avoid contact with others as much as possible. Monitor for symptoms of respiratory illness, such as fever, cough and difficulty breathing. If your symptoms worsen, you should contact your healthcare provider. If you experience a medical emergency at any time you should call 911. For more information, please refer to the CDC website https://www.cdc.gov/coronavirus/2019-ncov/if-you-are-sick/index.html
You may have an elevated likelihood of having contracted the novel Coronavirus/COVID-19 so you may want to be tested.
You are currently not in one of the locations that we're servicing with our at-home screening and testing solution. Please leave your contact information below if you'd like to be notified when our solution becomes available in your location. In the meantime, you can visit drive-through locations or assessment centers in your area.
You may have an elevated likelihood of having contracted the novel Coronavirus/COVID-19
You may have an elevated likelihood of having contracted the novel Coronavirus/COVID-19 so you qualify
for our at-home screening and testing solution. You are currently in one of the locations that we're servicing with our at-home screening and testing solution. You can find out more about how our at-home screening and testing solution works on our website. You can order it by clicking the buy button.
$135
LEARN MOREWe do NOT make any money off these tests and we are committed to seeking reimbursement on behalf of patients whenever possible.
For more information about payment, refer to the FAQ section of our website.
imaware™ is working with local governments, businesses, physician networks and more to provide efficient and safe screening for the COVID-19 virus. To date, we’ve screened over 10,000 patients and tested over 1000
imaware™ offers a comprehensive approach to screening and managing COVID-19 risk across workplaces. Reach out to us to learn more
Daily and weekly screening and risk assessments for your employees to enhance awareness of COVID-19 at your workplace
Our partnered physician networks can provide appropriate testing and care for your workers
Workers will receive a “back to work” certificate once they are cleared demonstrating their test results
Coronaviruses are a large family of viruses which can lead to illness in humans or animals. Several coronaviruses have caused respiratory infections in humans including Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS).
The most recently discovered coronavirus causes coronavirus disease COVID-19 which was unknown before the outbreak began in December 2019 in Wuhan, China.
There still isn't enough information to fully characterize the symptoms associated with COVID-19. Based on preliminary data, signs and symptoms may appear within 2-14 days after exposure to the virus. However, some confirmed cases have also been shown to be asymptomatic. Symptoms can include the following:
The virus that causes COVID-19 seems to be spreading easily from person-to-person. Someone who is actively sick with COVID-19 can spread the illness to others. Early data suggests a person actively sick with COVID-19 can transmit the virus to around 2.3 other people. Due to this, it's recommended to engage in preventative actions to protect yourself and others.
• Thoroughly wash all surfaces of your hands often with soap and water for at least 20 seconds, or, if this isn’t available, use a hand sanitizer that contains at least 60% alcohol
• Avoid touching your eyes, nose, and mouth, especially with unwashed hands
• Avoid close contact with people who are sick and stay home if you are sick
• Avoid crowds and non-essential travel as much as possible
• Wear a facemask only if you are sick or you are caring for someone who is sick.
Please visit https://www.cdc.gov/coronavirus/2019-nCoV/index.html for the most up-to-date information
Our Help Center provides useful guides and answers to our most frequently asked questions. You can also email us at support@imaware.health
visit help center
Our CLIA-certified national lab provider offers The SARS-CoV-2 (COVID-19) test that uses the FDA Emergency Use Authorization (EUA) approved CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time Reverse Transcriptase (RT)-PCR Diagnostic Panel, that’s intended for the detection of COVID-19 in individuals who meet CDC or public health criteria for COVID-19 testing.
It's important to note that:
1) This test has not been FDA cleared or approved
2) This test has been authorized by FDA under an EUA for use by authorized laboratories;
3) This test has been authorized only for the detection of nucleic acid from 2019-nCoV, not for any other viruses or pathogens, and;
4) This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of SARS-CoV-2 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
imaware™’s testing for COVID-19 is administered with a swab that is inserted into the nostril to reach the nasopharyngeal region, from where cells are collected -- a process that can make self-collection difficult. A healthcare professional is sent to the patient’s home to administer the test, deliver the sample to the lab and return accurate, easy-to-understand results. An independent telemedicine clinician under the Wheel network reviews the results and reaches out to patients testing positive for the virus with care instructions.
The imaware™ remote screening and testing solution is $135. Patients pay the fee online at checkout, prior to requesting an at-home sample collection. All fees include the screening, on-site testing by a healthcare professional, sample processing, results and follow up by an independent telemedicine clinician if needed.
Many municipalities, like Houston, are offering free drive through testing to meet the needs of the low-medium risk population. imaware™ is specifically intended for vulnerable, high-risk individuals. As of now, private testing is not being subsidized by the federal or state government. We are providing this solution at cost
Patients can expect test results back within 72 hours after a healthcare professional collects their test sample.
The imaware™ test is set apart from other at-home options by the lower margin for error, due to the test being administered by a healthcare professional. While other types of tests requiring blood or saliva samples are simpler to self-collect, self-collected COVID-19 swab tests are at a greater risk for inaccurate results.
imaware™ adds patient-centric care to the equation post diagnosis through its superior telemedicine consult, Wheel, to help patients navigate symptoms through to recovery.
